Skylynn Thangwaritorn, Abel Thomas, Christopher Lee, Suliman Ghafary, Dominic Rivera, Joel Varughese, Yu Zeyu, Pemminati Sudhakar
Department of Biomedical Education, California Health Sciences University College of Osteopathic Medicine, Clovis, USA.
Department of Pharmacology, California Health Sciences University College of Osteopathic Medicine, Clovis, USA.
Cureus. 2024 Jan 3;16(1):e51608. doi: 10.7759/cureus.51608. eCollection 2024 Jan.
This comprehensive literature review addresses the scarcity and limited study of hypotension treatments compared to abundant antihypertensive drugs. Hypotension, categorized as absolute, relative, or orthostatic, has diverse causes. This review explores various treatments, including drugs affecting the sympathetic nervous system, such as midodrine, dihydroergotamine, and ergotamine, which have shown efficacy in managing hypotension. Dopamine agonists/antagonists and other drugs such as ephedrine, norepinephrine, and fludrocortisone are also discussed, each with distinct mechanisms and applications. Additionally, adjunctive agents such as non-steroidal anti-inflammatory agents, caffeine, and monoamine oxidase inhibitors are reviewed for their effects on blood pressure. This review underscores the importance of understanding the efficacy and safety profiles of hypotension treatments to guide healthcare professionals in optimal drug selection and management, emphasizing the need for further research and comparative studies for evidence-based guidelines.
与丰富的抗高血压药物相比,低血压治疗的研究稀缺且有限,本综合性文献综述探讨了这一问题。低血压分为绝对性、相对性或体位性,病因多样。本综述探讨了各种治疗方法,包括影响交感神经系统的药物,如米多君、双氢麦角胺和麦角胺,这些药物在治疗低血压方面已显示出疗效。还讨论了多巴胺激动剂/拮抗剂以及其他药物,如麻黄碱、去甲肾上腺素和氟氢可的松,每种药物都有不同的作用机制和应用。此外,还综述了非甾体抗炎药、咖啡因和单胺氧化酶抑制剂等辅助药物对血压的影响。本综述强调了了解低血压治疗的疗效和安全性概况对于指导医疗保健专业人员进行最佳药物选择和管理的重要性,强调需要进一步研究和比较研究以制定循证指南。